AI-generated summary
This review examines transcranial photobiomodulation, a non-invasive use of red or near-infrared light, as a possible approach for ischemic stroke. The authors describe stroke pathology and proposed light-related mechanisms, and report that preclinical and clinical evidence suggests potential benefits across acute, subacute and chronic phases. The abstract does not quantify these benefits, so the evidence should be considered preliminary.
- Who or what was studied
- Patients with ischemic stroke, as well as preclinical and clinical evidence referenced in the review
- Wavelengths
- 630, 1300 nm
- Limits stated in the abstract
- The abstract is a narrative review with no pooled numerical results, and the strength of the reported preclinical and clinical evidence is not stated.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Ischemic stroke (IS), comprising 65.3% of the 11.9 million new stroke cases worldwide in 2021, is a leading cause of disability and mortality due to cerebral vascular occlusion and subsequent ischemia. The increasing prevalence, particularly in aging populations such as China, underscores the urgent need for novel therapeutic strategies. Conventional treatments, including thrombolysis and surgery, are constrained by narrow therapeutic windows and risks such as hemorrhage. Transcranial photobiomodulation (tPBM), a non-invasive technique utilizing red or near-infrared light (630-1300 nm), has emerged as a promising intervention for IS. This review synthesizes the pathological features of IS, including blood-brain barrier disruption, oxidative stress, and neuroinflammation, and elucidates the molecular mechanisms of tPBM, such as enhanced mitochondrial function, increased cerebral blood flow, and upregulation of neurotrophic factors. Preclinical and clinical evidence demonstrate tPBM's potential to mitigate neuronal damage and promote recovery across acute, subacute, and chronic phases of IS. By evaluating current applications, this study aims to provide a theoretical foundation for optimizing treatment parameters, enhancing clinical outcomes, and guiding future rehabilitation strategies for patients with stroke.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 630-1300 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Transcranial photobiomodulation, Stroke, Photobiomodulation, Cerebral blood flow, Neuroinflammation, Oxidative stress, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.